(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

R ROSEMONT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

R ROSEMONT

ST13

US500000097258471

Class

5, 42, 44

Filing

97258471

Registration

7362691

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

23

Latest update

07/23/2025

Trademark type

Combined

Nice classes

5, 42, 44

Filing date

02/08/2022

Registration date

04/23/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/23/2024

Last transaction

07/23/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

Drawing code

5

Owner type

99

Owner location

DEVON, GB

Examiner

SOMERVILLE, ARETHA

Law office

L70

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the word "ROSEMONT" underneath a stylized letter "R".

Holders and representatives

Holders

Rosemont Pharmaceuticals Ltd
Rosemont Pharmaceuticals Ltd

Representatives

Bradley M. Stohry Reichel Stohry Dean LLP

Technical classification

Nice Classes

Class 5Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for patients sufferings from dysphagia or otherwise requiring medication in liquid form; sanitary preparations for medical use; dietetic preparations adapted for medical purposes substances; drugsmedicines and medical preparationsoral liquid medicinesoral suspensionsdispersible or soluble tabletspowders to be consumed in liquid form that facilitate the delivery of pharmaceutical preparations

Class 42

Scientific research; research and testing relating to drugspharmaceuticalsmedicines and medical preparations and consultation regarding drug development

Class 44

Medical and pharmaceutical consultation

Publications

History of USPTO decisions and trademark events.

23 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/17/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/17/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/17/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/17/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/17/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/23/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

04/23/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/06/2024

PUBO

PUBLISHED FOR OPPOSITION

02/06/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/17/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/30/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/22/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/22/2023

ALIE

ASSIGNED TO LIE

11/22/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/20/2023

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

04/06/2023

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

04/06/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

01/09/2023

GNRT

NON-FINAL ACTION E-MAILED

01/09/2023

CNRT

NON-FINAL ACTION WRITTEN

01/09/2023

DOCK

ASSIGNED TO EXAMINER

11/19/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/14/2022

NWAP

NEW APPLICATION ENTERED

02/11/2022

Continuous trademark protection

Get notified about every new filing that threatens R ROSEMONT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.